Onego Bio to Establish Flagship Manufacturing Facility in Jefferson County, Wisconsin

US-Finnish company Onego Bio is planning to establish a new manufacturing facility in Jefferson County, Wisconsin, focusing on producing its animal-free egg protein, Bioalbumen®. The facility, located within the Food and Beverage Innovation Campus, will aim to replicate the taste, nutrition, and functionality of traditional egg proteins while reducing environmental impact and addressing supply chain issues. With the capacity to produce the equivalent of output from six million laying hens, the facility is expected to be operational by 2028.

Onego Bio's expansion comes after the company opened a commercial headquarters in San Diego, California, and secured $15.2 million in funding, bringing its total to $70.8 million. The company submitted a Generally Recognized as Safe (GRAS) notification to the U.S. Food and Drug Administration (FDA) for Bioalbumen®. CEO Maija Itkonen emphasized the commitment to building a resilient and sustainable food system, ensuring stability for manufacturers, reducing supply chain volatility, and supporting long-term food security. The company aims to bring the benefits of Bioalbumen® to more customers through this new facility.